PpGalNac T1 as a potential novel marker for human bladder cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5653-5657

  Ding, Ming Xia ^a   Wang, Hai Feng ^a   Wang, Jian Song ^a   Zhan, Hui ^a   Zuo, Yi Gang ^a   Yang, De Lin ^a   Liu, Jing Yu ^a   Wang, Wei ^a   Ke, Chang Xing ^a   Yan, Ru Ping ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder carcinoma; Glycosylation; Glycosyltransferase; ppGalNAc T1; RNAi

Indexed keywords

EID: 84874064743     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5653     Document Type: Article

References (13)

1. Banks DD (2011). The effect of glycosylation on the folding kinetics of erythropoietin. J Mol Biol, 412, 536-50.
2. Boscher C, Dennis JW, Nabi IR (2011). Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol, 23, 383-92.
3. Brooks SA, Carter TM, Bennett EP, et al (2007). Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. Acta Histochem, 109, 273-84.
4. Gallagher DJ, Milowsky MI, Gerst SR, et al (2010). Phase II study of sunitinib in patients with metastatic urothelial cancer. J Clin Oncol, 28, 1373-79.
5. Gao Y, Tu YB, Guo Y, et al (2011). PpGalNacT2 participating in vanadium-induced HL-60 cell differentiation. Mol Biol Rep, 38, 1483-9.
6. Gerken TA, Jamison O, Perrine CL, et al (2011). Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J Biol Chem, 286, 14493-507.
7. Kato K, Takeuchi H, Kanoh A, et al (2010). Loss of UDPGalNAc: polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis. Glycoconj J, 27, 267-76.
8. Liu C, Lin D, Xu L, et al (2011). An anti-human ppGalNAcT-2 monoclonal antibody. Hybridoma (Larchmt), 30, 549-54.
9. Perrine CL, Ganguli A, Wu P, et al (2009). Glycopeptidepreferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2. J Biol Chem, 284, 20387-97.
10. Platt FM, Hurst CD, Taylor CF, et al(2009). Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Clin Cancer Res, 15, 6008-17.
11. Topaz O, Bergman R, Mandel U, et al(2005). Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis. Am J Dermatopathol, 27, 211-5.
12. Tran DT, Lim JM, Liu M, et al (2012). Glycosylation of a-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases. J Biol Chem, 287, 20967-74.
13. Zlocowski N, Sendra VG, Lorenz V, et al (2011). Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation. Biochem Biophys Res Commun, 410, 140-5.